USE OF NEGATIVELY CHARCHED PHOSPHOLIPIDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF MACULAR DEGENERATION
Negatively charged phospholipids, as well as compositions including negatively charged phospholipids and possibly carotenoids and/or antioxidants, for treating the eye are disclosed. In a preferred embodiment, a composition comprising at least one negatively charged phospholipid except cardiolipin i...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
18.06.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Negatively charged phospholipids, as well as compositions including negatively charged phospholipids and possibly carotenoids and/or antioxidants, for treating the eye are disclosed. In a preferred embodiment, a composition comprising at least one negatively charged phospholipid except cardiolipin is used to treat age-related macular degeneration. Methods for producing the negatively charged phospholipids, as well as methods for producing the compositions including negatively charged phospholipids and possibly carotenoids and/or antioxidants for treating age-related macular degeneration, are also disclosed. |
---|---|
Bibliography: | Application Number: EP20020754804 |